Neurotrope, Inc. (32)

Browse by Contract Category

Contracts

Tax Matters Agreement, dated as of December 6, 2020, by and between Neurotrope, Inc. and Neurotrope Bioscience, Inc (Filed With SEC on December 7, 2020)
Separation and Distribution Agreement, dated as of December 6, 2020, by and between Neurotrope, Inc. and Neurotrope Bioscience, Inc (Filed With SEC on December 7, 2020)
Form of the Amended and Restated Series E Warrant (Filed With SEC on September 30, 2020)
Form of Voting Agreement by and between Metuchen and certain stockholders of Neurotrope (Filed With SEC on September 30, 2020)
Second Amendment to Agreement and Plan of Merger, dated as of September 30, 2020, by and between Petros Pharmaceuticals, Inc., PM Merger Sub 1, LLC, PN Merger Sub 2, Inc.,... (Filed With SEC on September 30, 2020)
Employee Lease Agreement, dated as of July 23, 2020, by and between Neurotrope, Inc., Neurotrope Bioscience, Inc. and Metuchen Pharmaceuticals, LLC (Filed With SEC on July 24, 2020)
Warrant Amendment Agreement, dated as of September 29, 2020, by and between Neurotrope, Inc. and the holders of Series H warrants (Filed With SEC on September 30, 2020)
Warrant Amendment Agreement, dated as of September 29, 2020, by and between Neurotrope, Inc. and the holders of Series G warrants (Filed With SEC on September 30, 2020)
Warrant Amendment Agreement, dated as of September 29, 2020, by and between Neurotrope, Inc. and the holders of Series F warrants (Filed With SEC on September 30, 2020)
Warrant Amendment Agreement, dated as of September 29, 2020, by and between Neurotrope, Inc. and the holders of Series E warrants (Filed With SEC on September 30, 2020)
Form of Series D Common Stock Warrant (Series H Spin-Of Warrant) (Filed With SEC on September 30, 2020)
Form of Series C Common Stock Warrant (Series G Spin-Off Warrant) (Filed With SEC on September 30, 2020)
Form of Series B Common Stock Warrant (Series F Spin-Off Warrant) (Filed With SEC on September 30, 2020)
Form of Series A Common Stock Warrant (Series E Spin-Off Warrant) (Filed With SEC on September 30, 2020)
Form of the Amended and Restated Series H Warrant (Filed With SEC on September 30, 2020)
Form of the Amended and Restated Series G Warrant (Filed With SEC on September 30, 2020)
Form of the Amended and Restated Series F Warrant (Filed With SEC on September 30, 2020)
Services Agreement, by and between Worldwide Clinical Trials, Inc. and Neurotrope BioScience Inc., dated as of July 23, 2020 (Filed With SEC on July 29, 2020)
First Amendment to Agreement and Plan of Merger, dated as of July 23, 2020, by and between Petros Pharmaceuticals, Inc., PM Merger Sub 1, LLC, PN Merger Sub 2, Inc., Neurotrope,... (Filed With SEC on July 24, 2020)
Transfer Agreement, dated as of June 9, 2020, by and between the Company and BryoLogyx Inc (Filed With SEC on June 12, 2020)
Supply Agreement, dated as of June 9, 2020, by and between the Company and BryoLogyx Inc (Filed With SEC on June 12, 2020)
Form of Lock-Up Agreement, by and between Petros, Neurotrope, Metuchen and certain securityholders of Neurotrope and Metuchen (Filed With SEC on May 18, 2020)
Form of Metuchen Voting Agreement, by and between Neurotrope and certain unitholders of Metuchen (Filed With SEC on May 18, 2020)
Form of Neurotrope Voting Agreement, by and between Metuchen and certain stockholders of Neurotrope (Filed With SEC on May 18, 2020)
Agreement and Plan of Merger and Reorganization, dated as of May 17, 2020, by and among Petros, Neurotrope, Merger Sub 1, Merger Sub 2 and Metuchen (Filed With SEC on May 18, 2020)
Description of the Registrants securities (Filed With SEC on March 13, 2020)
Consulting Advisory Agreement dated as of January 22, 2020, by and between the Company and Katalyst Securities, LLC (Filed With SEC on January 23, 2020)
Form of Securities Purchase Agreement (Filed With SEC on January 23, 2020)
Form of Series H Common Stock Purchase Warrant (Filed With SEC on January 23, 2020)
Separation Agreement, dated October 23, 2019, between Neurotrope, Inc., Neurotrope Bioscience, Inc. and Michael F. Ciraolo, J.D., Ph.D (Filed With SEC on October 25, 2019)
Rights Agreement, dated as of September 9, 2019, between Neurotrope, Inc. and Philadelphia Stock Transfer, Inc., as rights agent (Filed With SEC on September 9, 2019)
Employment Agreement, dated March 29, 2019, between Neurotrope, Inc. and Michael Ciraolo (Filed With SEC on April 1, 2019)